At INC Research, our dedicated 1,000-strong CNS analgesia team are a flexible and nimble group who are ready to assist you with your clinical development program, whatever the size of your organization and study. We pride ourselves on our agility to scale our services to fit your precise requirements.

Thanks to our unique therapeutic Business Unit structure, we are able to provide offer tailored operations to ensure that we provide the exact level of resources you need.

Therapeutic depth across the board

We are uniquely suited to address the challenges you face in the development of analgesia products, formed solely as we are of analgesia experts at the cutting edge of research. In fact, our therapeutic depth goes right across the board, from our most senior executives through to our CRAs. In the past five years, our specialized team has been involved in over 106 analgesia studies.

Our specialist knowledge means that we understand current trends in analgesia, and are fully equipped to assist you in the development of new compounds and mechanisms of action. We’re used to being at the cutting edge of research.

High level strategic and operational input throughout

When you work with INC Research, you’ll appreciate the continuity of involvement from our senior personnel. They will stay with your clinical development program for the duration, with input and oversight on a daily basis, to ensure that your trial benefits from the high level strategic and operational attention it deserves.

We can proactively advise you on the design of your study program, as well as implement your clinical trials. And we will keep our eyes on enrollment data, developments, and potential ways to complete faster.

Experience in abuse liability studies

In the field of analgesia research and treatment development, where opioids have long been the mainstay of the management of moderate-severe pain, there is unfortunately the potential for the abuse and misuse of medication. At INC Research, we understand regulatory requirements for the approval of abuse-deterrent compounds and have the relevant experience in abuse liability studies. We can provide much-needed continuity in this area, throughout your whole clinical development process.

To find out more about how INC Research is uniquely suited to overcome the challenges of your CNS analgesia clinical development, please download our factsheet.


a This is an estimate of INC Research studies from the last five years that are completed or scheduled to complete for this therapy area.